TP53 and cancer: Not surprisingly, inactivation of the p53 pathway is a universal event in human cancers and p53 is one of the most highly mutated genes with greater than 60% of human malignancies harboring inactivating p53 mutations (reviewed by Vousden and Prives[1]; UMD TP53 mutation database at http://p53.fr/[2]).